Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.41 |
| ▸ | CIT | O14578 | 4/20 | 0.40 |
| ▸ | AAK1 | Q2M2I8 | 11/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7408066 | 0.88 | XIAP (0.55) | XIAPSMN1; SMN2LMNATP53MAPT | |
| SCHEMBL7642937 | 0.84 | XIAP (0.43) | XIAPS1PR1S1PR3CITAAK1 | |
| SCHEMBL7637784 | 0.82 | XIAP (0.43) | XIAPS1PR1S1PR3SMN1; SMN2LMNA | |
| SCHEMBL7643043 | 0.81 | LNPEP (0.42) | XIAPCIT | |
| Hydrochloric Acid SCHEMBL7403586 | 0.77 | RAB9A (0.41) | XIAPSMN1; SMN2LMNATP53MAPT | |
| SCHEMBL7408062 | 0.76 | XIAP (0.37) | XIAPSMN1; SMN2LMNA | |
| SCHEMBL7406241 | 0.73 | L3MBTL1 (0.36) | XIAPSMN1; SMN2LMNAMAPT | |
| SCHEMBL7642932 | 0.72 | XIAP (0.34) | XIAPSMN1; SMN2LMNA | |
| SCHEMBL7400265 | 0.71 | FCER2 (0.41) | — | |
| SCHEMBL8195939 | 0.71 | GAA (0.40) | SMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6468977-B1 | COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS | APOTEX INC. (CA) | 2002-10-22 | — | — | US | disclosed |
| CN-1291993-A | Thiadiazole compounds useful as cysteine activity dependent enzyme inhibitors | APOTEX INC (CA) | 2001-04-18 | — | — | CN | disclosed |